Skip to main content

selonabant

selonabant: 1 clinical trial tracked.

selonabant evidence translation

What we can confirm

1 tracked trial

No verified listed company relationship

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about selonabant, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence1 indications · 1 study sponsors
Clinical Trial Registry Records (1)

A Phase 1, Randomized, Double-Blind, Placebo Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Intravenous Selonabant in Healthy Adult Subjects Aged 18 to 30 Years

NCT07211607Registry updated 2026-05-08·Phase 1·ANEB
Completed

Primary endpoint: Number of Participants with Adverse Events

InterventionalRandomizedquadruple40 enrolledStarted 2025-09Completion 2026-051 site · United StatesAnebulo Pharmaceuticals